{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:6739b234-ac65-483b-bb06-337750f8d620", "type": "composite", "version": "1", "versioncreated": "2026-10-08T05:33:43.746289Z", "firstcreated": "2026-10-08T05:07:33.742422Z", "pubstatus": "usable", "language": "it", "headline": "Tumore del pancreas, AIOM: daraxonrasib non è disponibile in Italia, avviare subito l'uso compassionevole", "description_text": "Il farmaco è approvato dalla FDA negli Stati Uniti da agosto, ma la Revolution Medicines non ha ancora presentato il dossier all'Agenzia europea dei medicinali. L'AIOM chiede l'attivazione immediata del programma di uso compassionevole per i pazienti con neoplasia metastatica già trattati.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:bf48f15d-aaf6-4efe-bd63-f11d1dd4f72f", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-08T10:39:58.813654Z", "firstcreated": "2026-10-08T05:07:33.742422Z", "pubstatus": "usable", "urgency": 5, "language": "it", "headline": "Tumore del pancreas, AIOM: daraxonrasib non è disponibile in Italia, avviare subito l'uso compassionevole", "byline": "Giulia Sanna", "located": "Italy", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Filo Civico", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Filo Civico”. Set rel=canonical to https://filocivico.mib.news/mondo/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-l-uso-compassionevole/ when publishing on the web.", "description_text": "Il farmaco è approvato dalla FDA negli Stati Uniti da agosto, ma la Revolution Medicines non ha ancora presentato il dossier all'Agenzia europea dei medicinali. L'AIOM chiede l'attivazione immediata del programma di uso compassionevole per i pazienti con neoplasia metastatica già trattati.", "altids": {"mosaic": "bf48f15d-aaf6-4efe-bd63-f11d1dd4f72f", "story": "6739b234-ac65-483b-bb06-337750f8d620", "slug": "tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-l-uso-compassionevole"}, "subject": [{"name": "World", "rel": "direct", "literal": "world", "code": "medtop:11000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/11000000"}], "place": [{"name": "Italy", "literal": "it", "code": "IT", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:d57c574b-0514-49a7-8e38-11365c287d4e", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "TUMORE DEL PANCREAS, DARAXONRASIB NON ANCORA DISPONIBILE IN ITALIA. AIOM: “SIA AVVIATO SUBITO IL PROGRAMMA DI USO COMPASSIONEVOLE”", "description_text": "Tumore del pancreas, AIOM: daraxonrasib non è disponibile in Italia, avviare subito l'uso compassionevole", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "d57c574b-0514-49a7-8e38-11365c287d4e"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-08T10:39:59.013139Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "our_page_url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/16a03b26f1f1c0a505a4938a9844421162ad30c0eeff1af2da0cfd5d590295e5.jpg", "mimetype": "image/jpeg", "width": 244, "height": 206}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:6739b234-ac65-483b-bb06-337750f8d620", "slug": "tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-luso-compassionevole-20261008", "status": "updated", "languages": ["it"], "item_count": 2, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Filo Civico", "canonical_required": true, "canonical_url": "https://filocivico.mib.news/mondo/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-l-uso-compassionevole/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Questo articolo è stato prodotto con l’ausilio dell’IA sotto la responsabilità editoriale di Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-08T10:39:58.824886Z"}, "sources": []}, "wireva:publication": {"name": "Filo Civico", "domain": "filocivico.mib.news", "country": "IT", "url": "https://filocivico.mib.news/mondo/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-l-uso-compassionevole/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/bf48f15d-aaf6-4efe-bd63-f11d1dd4f72f", "html": "https://wireva.mib.news/item/bf48f15d-aaf6-4efe-bd63-f11d1dd4f72f/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-l-uso-compassionevole/", "story": "https://wireva.mib.news/story/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-luso-compassionevole-20261008/"}, "wireva:metrics": {"word_count": 482, "char_count": 3369, "reading_time_seconds": 241}}}, "item-1": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:d4db6a48-e521-4ba5-8c8a-e7bcee1c647a", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-08T10:39:59.001500Z", "firstcreated": "2026-10-08T05:33:43.746289Z", "pubstatus": "usable", "urgency": 5, "language": "it", "headline": "Tumore del pancreas, AIOM chiede l'uso compassionevole del daraxonrasib", "byline": "Alessia Amato", "located": "Italy", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Ascensio", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Ascensio”. Set rel=canonical to https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/ when publishing on the web.", "description_text": "Il farmaco approvato dalla FDA negli Stati Uniti non è ancora disponibile in Italia. L'AIOM sollecita l'avvio immediato del programma di uso compassionevole per i pazienti con neoplasia metastatica già trattati.", "altids": {"mosaic": "d4db6a48-e521-4ba5-8c8a-e7bcee1c647a", "story": "6739b234-ac65-483b-bb06-337750f8d620", "slug": "tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Italy", "literal": "it", "code": "IT", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:d57c574b-0514-49a7-8e38-11365c287d4e", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "TUMORE DEL PANCREAS, DARAXONRASIB NON ANCORA DISPONIBILE IN ITALIA. AIOM: “SIA AVVIATO SUBITO IL PROGRAMMA DI USO COMPASSIONEVOLE”", "description_text": "Tumore del pancreas, AIOM: daraxonrasib non è disponibile in Italia, avviare subito l'uso compassionevole", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "d57c574b-0514-49a7-8e38-11365c287d4e"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-08T10:39:59.013139Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "our_page_url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/16a03b26f1f1c0a505a4938a9844421162ad30c0eeff1af2da0cfd5d590295e5.jpg", "mimetype": "image/jpeg", "width": 244, "height": 206}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:6739b234-ac65-483b-bb06-337750f8d620", "slug": "tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-luso-compassionevole-20261008", "status": "updated", "languages": ["it"], "item_count": 2, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Ascensio", "canonical_required": true, "canonical_url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Questo articolo è stato prodotto con l’ausilio dell’IA sotto la responsabilità editoriale di Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-08T10:39:59.010160Z"}, "sources": []}, "wireva:publication": {"name": "Ascensio", "domain": "ascensio.uno", "country": "IT", "url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/d4db6a48-e521-4ba5-8c8a-e7bcee1c647a", "html": "https://wireva.mib.news/item/d4db6a48-e521-4ba5-8c8a-e7bcee1c647a/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/", "story": "https://wireva.mib.news/story/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-luso-compassionevole-20261008/"}, "wireva:metrics": {"word_count": 413, "char_count": 2855, "reading_time_seconds": 204}}}}, "extra": {"wireva:languages": ["it"], "wireva:status": "updated", "wireva:item_count": 2}}